ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CME vs BAC // GROSS PROFIT MARGIN

CME Group Inc. (NASDAQ) VS. Bank of America Corporation (NYSE) • 15-METRIC TALLY: CME 8 — BAC 4
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CME VS. BAC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CME BAC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 3.50% 2.50% +1.00 CME /roic <GO>
EV/EBITDA & P/E Valuation 40.2x 30.2x +10.00 BAC /valuation <GO>
Free Cash Flow Yield 3.95% 2.10% +1.85 CME /fcf-yield <GO>
Operating Margin 64.90% 32.90% +32.00 CME /operating-margins <GO>
Net Profit Margin 62.50% 27.00% +35.50 CME /net-margins <GO>
Revenue Growth (YoY) 6.40% 6.80% -0.40 BAC /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 3.71% 0.00% +3.71 CME /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 8/9 7/9 +1.00 CME /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 57.6 38.3 +19.30 CME /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.01 0.90 +0.11 CME /macro-sensitivity <GO>
Forward P/E Multiple 24.3x 10.9x +13.40 BAC /forward-pe <GO>
Enterprise Scale & Market Cap $106.10B $357.61B -$251.51B BAC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CME REV BAC REV CME GROSS % BAC GROSS % CME FCF BAC FCF
FY 2025 $6.52B $113.10B — — $4.19B $7.52B
FY 2024 $6.13B $105.86B — — $3.60B -$13.57B
FY 2023 $5.58B $102.77B — — $3.20B $40.36B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CME // BETA 1.01
BAC // BETA 0.90